ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today

Page 2 of 2

Inventergy Global Inc. (NASDAQ:INVT) shares are up by over 11% today after it announced that one of its subsidiary’s new partners, Pabellon Inc., is engaged with a Fortune 100 company with the purpose of creating a proof of concept for demonstrating Inventergy’s Surface Plane Magnetic Technology. The company’s CEO said that the engagement shows the extent of value created by Inventergy Global for its partners through its unique monetization model. Inventergy Global is engaged in the business of Intellectual Property investment and licensing. Two of the hedge funds in our system owned shares of Inventergy Global Inc. (NASDAQ:INVT) at the end of June.

Follow Inventergy Global Inc. (NASDAQ:INVT)

Array BioPharma Inc. (NASDAQ:ARRY)‘s stock hit its 52-week high today a day after the news of positive phase III data was released related to its combination of encorafenib (BRAF inhibitor) and binimetinib (MEK inhibitor) for treating BRAF-mutant advanced, unresectable or metastatic melanoma. The results of the study showed that the combination significantly improved progression-free survival in comparison to Roche’s Zelboraf alone, meeting its primary endpoint. Jefferies’ responded by raising its price target on Array to $8.00 today from $7.00. However, after being up by as much as 7% in pre-market trading, shares of the company are now down by 3% today after gaining 81% yesterday. 17 hedge funds that we track held about $217 million worth of Array BioPharma Inc. (NASDAQ:ARRY)’s stock as of the end of the June quarter, amounting to 42.60% of its shares.

Follow Array Biopharma Inc (NASDAQ:ARRY)

EndoChoice Holdings Inc. (NYSE:GI) shares shot up on the news of the company’s buyout by Boston Scientific Corporation (NYSE:BSX). The deal is worth $421 million and will help Boston Scientific expand its endoscopy portfolio. The purchase price of $8 per share was an almost 100% premium to EndoChoice’s closing price of $4.22 yesterday, sending shares up by 89% today. The transaction is expected to be closed in the fourth quarter of this year. Seven of the hedge funds that we track owned $11 million worth of EndoChoice Holdings Inc. (NYSE:GI) shares at the end of June.

Follow Endochoice Holdings Inc.

Disclosure: None

Page 2 of 2